BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Campbell CM, Guha A, Haque T, Neilan TG, Addison D. Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review. J Clin Med 2020;9:E2935. [PMID: 32932930 DOI: 10.3390/jcm9092935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Mavrogeni S, Pepe A, Nijveldt R, Ntusi N, Sierra-Galan LM, Bratis K, Wei J, Mukherjee M, Markousis-Mavrogenis G, Gargani L, Sade LE, Ajmone-Marsan N, Seferovic P, Donal E, Nurmohamed M, Cerinic MM, Sfikakis P, Kitas G, Schwitter J, Lima JAC, Dawson D, Dweck M, Haugaa KH, Keenan N, Moon J, Stankovic I, Donal E, Cosyns B. Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2022:jeac134. [PMID: 35808990 DOI: 10.1093/ehjci/jeac134] [Reference Citation Analysis]
2 Nicosia RF, Ligresti G, Caporarello N, Akilesh S, Ribatti D. COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury. Am J Pathol 2021;191:1374-84. [PMID: 34033751 DOI: 10.1016/j.ajpath.2021.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 Ferreto LED, Bortoloti DS, Fortes PCN, Follador F, Arruda G, Ximenez JP, Wendt GW. Dexamethasone for treating SARS-CoV-2 infection: a systematic review and meta-analysis. Sao Paulo Med J 2021;139:657-61. [PMID: 34644768 DOI: 10.1590/1516-3180.2021.0120.R1.30062021] [Reference Citation Analysis]
4 Ma H, Lim XC, Yu Q, Li Y, Li Y, Jia W. Ratios between circulating myeloid cells and lymphocytes are associated with mortality in severe COVID-19 patients. Open Medicine 2021;16:351-60. [DOI: 10.1515/med-2021-0237] [Reference Citation Analysis]
5 Umbrajkar S, Stankowski RV, Rezkalla S, Kloner RA. Cardiovascular Health and Disease in the Context of COVID-19. Cardiol Res 2021;12:67-79. [PMID: 33738009 DOI: 10.14740/cr1199] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Silberberg E, Filep JG, Ariel A. Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis. Front Immunol 2022;13:863449. [DOI: 10.3389/fimmu.2022.863449] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tammam SN, El Safy S, Ramadan S, Arjune S, Krakor E, Mathur S. Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2. J Control Release 2021;337:258-84. [PMID: 34293319 DOI: 10.1016/j.jconrel.2021.07.028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]